Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Defense Health Agency · DEFENSE HEALTH AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT9402-26-Q-9401 in this department, oldest first.
- Aug 6, 2026 · this noticeSolicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
The Department of War (DoW) is required by law (10 U.S.C. � 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing pur… (show all)
poses, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: The following November 2026 drug classes/subclasses will be reviewed: a. Atopy - Topical Agents Anzupgo Eucrisa Opzelura Vtama Zoryve b. Lung Cancer - METEX14 Tabrecta Tepmetko The RFQ, including UF BPA and UF ADP appendices, are attached herein. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9401. Pre-quotation teleconference is on August 12, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Match: Same agency (Defense Health Agency), same NAICS 325412.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SIRTEX MEDICAL INC | 2 | $45K | Aug 19, 2026 |
| Novartis Pharmaceuticals Corporation | 1 | $5.0M | Jan 29, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH | 1 | $2.4M | Oct 1, 2026 |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 1 | $900K | Aug 12, 2026 |
| INO THERAPEUTICS LLC | 1 | $404K | Mar 12, 2025 |
| BOSTON SCIENTIFIC CORP · $BSX | 1 | $350K | Aug 21, 2026 |
| AGILENT TECHNOLOGIES INC · $A | 1 | $350K | Oct 6, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Oct 6, 2026AGILENT TECHNOLOGIES INC$350KIHC Reagents and Supplies
- Oct 1, 2026CARDINAL HEALTH 414, LLC$2.4MFDA-Approved Radiopharmaceutical Supplies and Cold Kits
- Aug 21, 2026BOSTON SCIENTIFIC CORP$350KY-90 Glass Theraspheres
- Aug 19, 2026SIRTEX MEDICAL INC$23KSIRTEX SIR-Spheres Y-90 Microspheres
- Aug 12, 2026CENTRAL ADMIXTURE PHARMACY SERVICES, INC$900KPre-Mixed IV Fluids, cardioplegic solutions, and specialized Total Parenteral Nutrition
- Jun 25, 2026SIRTEX MEDICAL INC$21KAward to SIRTEX MEDICAL, INC.
- Jan 29, 2026Novartis Pharmaceuticals Corporation$5.0MPluvicto and Lutathera 5 Year BPA
- Mar 12, 2025INO THERAPEUTICS LLC$404KNotice of Intent to Sole Source Neonatal Pediatric Inhaled Nitric Oxide (INO) Gas
Competitive landscape
For the 7 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (4 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- $60K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 3 of the past winners are listed companies
- 5 insider buys and 8 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.